Medistim ASA reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was NOK 116.49 million compared to NOK 102.14 million a year ago. Revenue was NOK 116.49 million compared to NOK 102.14 million a year ago. Net income was NOK 24.65 million compared to NOK 18.8 million a year ago. Basic earnings per share from continuing operations was NOK 1.35 compared to NOK 1.03 a year ago. Diluted earnings per share from continuing operations was NOK 1.35 compared to NOK 1.03 a year ago.
For the nine months, sales was NOK 350.11 million compared to NOK 309.24 million a year ago. Revenue was NOK 350.11 million compared to NOK 314.54 million a year ago. Net income was NOK 81.5 million compared to NOK 74.79 million a year ago. Basic earnings per share from continuing operations was NOK 4.47 compared to NOK 4.11 a year ago. Diluted earnings per share from continuing operations was NOK 4.46 compared to NOK 4.1 a year ago.